OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 28, 2023
It has been a long wait, but for Alzheimer’s at least, this is the beginning of renewed hope.
August 01, 2023
A proposed database includes key information about critical drugs, such as the country of origin and quantity, so supply chain weaknesses can be identified.
July 01, 2023
The debate surrounding drug pricing changes rages on.
June 01, 2023
COVID-19 has raised the specter of pandemic planning and the question of what can be done now to prevent future disaster.
May 01, 2023
The engine that drives pharmaceuticals forward, its workforce, is now very low on fuel.
April 01, 2023
Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.
March 01, 2023
That wave beginning to crash over PhRMA’s gunwales may well emanate from a startup mindset, rather than Big Pharma or government policy pundits.
February 01, 2023
The restraint to not target solely the major disease groups has provided good proportion and balance for our industry.
January 01, 2023
Cell and gene therapies is unequivocally viewed as the biggest opportunity in the bio/pharma space.
December 01, 2022
Science news can be just so weird, or weirdly useful, that everything else recedes as we ponder whether it is true and what consequences it might bring.